Next-Generation Sequencing Identified a Novel Crizotinib-Sensitive PLB1-ALK Rearrangement in Lung Large-Cell Neuroendocrine Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Next-Generation Sequencing Identified a Novel Crizotinib-Sensitive PLB1-ALK Rearrangement in Lung Large-Cell Neuroendocrine Carcinoma

Published:2021-05 Issue:3 Volume:22 Page:e366-e370
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Wang Shuai,Wu Xuan,Zhao Jiuzhou,Chen Haiyang,Zhang Zhe,Wang Mingyue,Xu Cong,Wang Yongsen,Wang Lili,He Zhen,Wang Qiming

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference10 articles.

1. Advances in neuroendocrine lung tumors;Travis;Ann Oncol,2010

2. Carboplatin in combination with oral or intravenous etoposide for extra-pulmonary, poorly-differentiated neuroendocrine carcinomas;Frizziero;Neuroendocrinology,2019

3. CUX1-ALK, a novel ALK rearrangement that responds to crizotinib in non–small cell lung cancer;Zhang;J Thorac Oncol,2018

4. SRBD1-ALK, a novel ALK fusion gene identified in an adenocarcinoma patient by next-generation sequencing;Hou;J Thorac Oncol,2019

5. ALK-rearrangement neuroendocrine carcinoma of the lung: a comprehensive study of a rare case series and review of literature;Zheng;Onco Targets Ther,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two case reports: EML4-ALK rearrangement large cell neuroendocrine carcinoma and literature review;Frontiers in Oncology;2023-11-01

2. New gene signature from the dominant infiltration immune cell type in osteosarcoma predicts overall survival;Scientific Reports;2023-10-25

3. The Unmet Diagnostic and Treatment Needs in Large Cell Neuroendocrine Carcinoma of the Lung;Current Oncology;2023-07-27

4. Az alectinib és a tüdő kevert nagysejtes neuroendokrin carcinomája.;Orvosi Hetilap;2023-04-09

5. Case Report: A Pregnant Woman Diagnosed as ALK-Rearrangement Lung Large Cell Neuroendocrine Cancer With Brain Metastasis;Frontiers in Oncology;2022-02-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3